Fortune Brands Innovations expects full-year earnings in the range of $4.15 to $4.45 per share. This story was generated by Automated Insights ( http://automatedinsights.com/ap) using data from Zacks ...

CARLSBAD, Calif. (AP) — CARLSBAD, Calif. (AP) — ViaSat Inc. (VSAT) on Thursday reported a loss of $158.4 million in its fiscal third quarter. The Carlsbad, California-based company said it had a loss ...

Strattec Security Corp. (STRT) on Thursday reported net income of $1.3 million in its fiscal second quarter. The Milwaukee-based company said it had net income of 32 cents per share. Earnings, ...

The Carmel, Indiana-based company said it had net income of $1.58 per share. Earnings, adjusted for non-recurring gains, came to $1.31 per share. The results topped Wall Street expectations. The ...

For the current quarter ending in March, Linde expects its per-share earnings to range from $3.85 to $3.95. The company expects full-year earnings in the range of $16.15 to $16.55 per share.

Today's Research Daily features the Q4 earnings season scorecard and updated analyst reports on 16 major stocks, including Meta Platforms, Mastercard and Adobe, as well as two micro-cap stocks ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.

InterDigital Inc. (IDCC) on Thursday reported fourth-quarter earnings of $133.1 million. The Wilmington, Delaware-based company said it had profit of $4.

Stock analysts at Zacks Research cut their FY2024 earnings estimates for shares of American Financial Group in a research note issued to investors on Monday, February 3rd. Zacks Research analyst T. De ...

Equities research analysts at Zacks Small Cap cut their FY2025 earnings per share estimates for shares of Protalix BioTherapeutics in a report released on Monday, February 3rd. Zacks Small Cap analyst ...

South Atlantic Bancshares, Inc. (SABK) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful ...

Zacks Investment Research has recently initiated coverage of bioAffinity Technologies, Inc. BIAF, assigning a "Neutral" recommendation to the company's shares. This assessment comes amid a mixed ...